scispace - formally typeset
Search or ask a question
Institution

American Cancer Society

NonprofitAtlanta, Georgia, United States
About: American Cancer Society is a nonprofit organization based out in Atlanta, Georgia, United States. It is known for research contribution in the topics: Cancer & Population. The organization has 1339 authors who have published 3700 publications receiving 688166 citations. The organization is also known as: American Cancer Society, ACS & American Society for the Control of Cancer.


Papers
More filters
Journal ArticleDOI
TL;DR: In this paper, the authors measured age-, sex-, and race-specific risks of lung cancer incidence and mortality among never tobacco smokers among more than 940,000 adults who reported no history of smoking at enrollment in either of two large American Cancer Society Cancer Prevention Study cohorts during 1959-1972 and 1982-2000 (CPS-II).
Abstract: BACKGROUND Few studies have directly measured the age-, sex-, and race-specific risks of lung cancer incidence and mortality among never tobacco smokers. Such data are needed to quantify the risks associated with smoking and to understand racial and sex disparities and temporal trends that are due to factors other than active smoking. METHODS We measured age-, sex-, and race-specific rates (per 100,000 person-years at risk) of death from lung cancer among more than 940,000 adults who reported no history of smoking at enrollment in either of two large American Cancer Society Cancer Prevention Study cohorts during 1959-1972 (CPS-I) and 1982-2000 (CPS-II). We compared lung cancer death rates between men and women and between African Americans and whites and analyzed temporal trends in lung cancer death rates among never smokers across the two studies by using directly age-standardized rates as well as Poisson and Cox proportional hazards regression analyses. All statistical tests were two-sided. RESULTS The age-standardized lung cancer death rates among never-smoking men and women in CPS-II were 17.1 and 14.7 per 100,000 person-years, respectively. Men who had never smoked had higher age-standardized lung cancer death rates than women in both studies (CPS-I: hazard ratio [HR] = 1.52, 95% confidence interval [CI] = 1.28 to 1.79; CPS-II: HR = 1.21, 95% CI = 1.09 to 1.36). The rate was higher among African American women than white women in CPS-II (HR = 1.43, CI = 1.11 to 1.85). A small temporal increase (CPS-II versus CPS-I) in lung cancer mortality was seen for white women (HR = 1.25, CI = 1.12 to 1.41) and African American women (HR = 1.22, CI = 0.64 to 2.33), but not for white men (HR = 0.89, CI = 0.74 to 1.08). Among white and African American women combined, the temporal increase was statistically significant only among those aged 70-84 years (P < .001). CONCLUSIONS Contrary to clinical perception, the lung cancer death rate is not higher in female than in male never smokers and shows little evidence of having increased over time in the absence of smoking. Factors that affect the interpretation of lung cancer trends are discussed. Our novel finding that lung cancer mortality is higher among African American than white women never smokers should be confirmed in other studies.

281 citations

Journal ArticleDOI
TL;DR: Kidney stone prevalence increased with age until age 70, then declined and was higher in men than women and in whites than blacks, and among Hispanic and Asian men was intermediate between that of whites and blacks.

280 citations

Journal ArticleDOI
Zsofia Kote-Jarai, Olama Aaa.1, G.G. Giles2, G.G. Giles3, Gianluca Severi3, Gianluca Severi2, Johanna Schleutker4, Maren Weischer5, Daniele Campa6, Elio Riboli7, Timothy J. Key8, Henrik Grönberg9, David J. Hunter10, Peter Kraft10, Michael J. Thun11, Sue A. Ingles12, Stephen J. Chanock13, Stephen J. Chanock14, Demetrius Albanes13, Richard B. Hayes15, David E. Neal1, David E. Neal16, Freddie C. Hamdy8, Jenny L Donovan17, Paul D.P. Pharoah1, Fredrick R. Schumacher12, Brian E. Henderson12, Janet L. Stanford18, Janet L. Stanford19, Elaine A. Ostrander13, Karina Dalsgaard Sørensen20, Thilo Dörk21, Gerald L. Andriole22, Joanne L. Dickinson23, Cezary Cybulski24, Jan Lubinski24, Amanda B. Spurdle25, Judith A. Clements26, Suzanne K. Chambers27, Joanne F. Aitken, Gardiner Raf.28, S. N. Thibodeau29, D J Schaid29, Esther M. John30, Esther M. John31, Christiane Maier32, W. Vogel32, Kathleen A. Cooney33, Jong Y. Park34, Lisa A. Cannon-Albright35, Lisa A. Cannon-Albright36, Hermann Brenner, Tomonori Habuchi37, Zhang H-W.38, Lu Y-J.39, Radka Kaneva40, Kenneth Muir41, Sara Benlloch1, Daniel Leongamornlert, Ed Saunders, Malgorzata Tymrakiewicz, N. Mahmud, Michelle Guy, Lynne T. O'Brien, R A Wilkinson, Amanda L. Hall, E J Sawyer, Tokhir Dadaev, Jonathan J. Morrison1, David P. Dearnaley42, David P. Dearnaley43, Alan Horwich42, Alan Horwich43, Robert Huddart43, Robert Huddart42, Vincent Khoo43, Vincent Khoo42, Chris Parker43, Chris Parker42, N. van As44, C.R.J. Woodhouse44, A. Thompson44, Timothy J. Christmas44, Chris Ogden44, Colin Cooper, Aritaya Lophatonanon41, Melissa C. Southey3, John L. Hopper3, Dallas R. English3, Dallas R. English2, T. Wahlfors, Tammela Tlj., Peter Klarskov5, Børge G. Nordestgaard5, Martin Andreas Røder5, Anne Tybjærg-Hansen45, Stig E. Bojesen5, Ruth C. Travis8, Federico Canzian6, Rudolph Kaaks6, Fredrik Wiklund9, Markus Aly9, Sara Lindström10, W. R. Diver11, Susan M. Gapstur11, Mariana C. Stern12, Roman Corral12, Jarmo Virtamo46, Angela Cox47, Christopher A. Haiman12, Loic Le Marchand48, Liesel M. FitzGerald19, Suzanne Kolb19, Erika M. Kwon13, Danielle M. Karyadi13, Torben F. Ørntoft20, Michael Borre20, Andreas Meyer21, Jürgen Serth21, Meredith Yeager13, Sonja I. Berndt13, James R. Marthick23, Briony Patterson23, Dominika Wokołorczyk24, Jyotsna Batra26, Felicity Lose25, Shannon K. McDonnell29, Amit Joshi30, A Shahabi30, Antje E. Rinckleb32, A Ray34, T A Sellers34, Lin H-Y.34, Robert A. Stephenson36, J. M. Farnham36, Heiko Müller6, Dietrich Rothenbacher6, Norihiko Tsuchiya37, Shintaro Narita37, Cao G-W.38, C. Slavov, Vanio Mitev40, Douglas F. Easton1, Rosalind A. Eeles43, Rosalind A. Eeles42 
TL;DR: The results of stage 3 are reported, in which 1,536 SNPs are evaluated in 4,574 individuals with prostate cancer (cases) and 4,164 controls and a SNP in TERT more strongly associated with PrCa than that previously reported is identified.
Abstract: Prostate cancer (PrCa) is the most frequently diagnosed male cancer in developed countries. We conducted a multi-stage genome-wide association study for PrCa and previously reported the results of the first two stages, which identified 16 PrCa susceptibility loci. We report here the results of stage 3, in which we evaluated 1,536 SNPs in 4,574 individuals with prostate cancer (cases) and 4,164 controls. We followed up ten new association signals through genotyping in 51,311 samples in 30 studies from the Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome (PRACTICAL) consortium. In addition to replicating previously reported loci, we identified seven new prostate cancer susceptibility loci on chromosomes 2p11, 3q23, 3q26, 5p12, 6p21, 12q13 and Xq12 (P = 4.0 × 10(-8) to P = 2.7 × 10(-24)). We also identified a SNP in TERT more strongly associated with PrCa than that previously reported. More than 40 PrCa susceptibility loci, explaining ∼25% of the familial risk in this disease, have now been identified.

279 citations

Journal ArticleDOI
23 Aug 2004-Oncogene
TL;DR: As the mechanisms underlying human carcinogenesis are better understood, dietary research will focus increasingly on intermediate markers such as the insulin-like growth factors and potentially carcinogenic metabolites.
Abstract: Dietary effects are presumed to underlie many of the large international differences in incidence seen for most cancers. Apart from alcohol and a few micronutrients, however, the role of specific nutritional factors remains ill-defined. The evidence for a role of energy balance, physical inactivity, and obesity has strengthened, while for dietary fat it has weakened. Phytochemicals such as folate, lycopene and flavonoids are still the subject of active research. As the mechanisms underlying human carcinogenesis are better understood, dietary research will focus increasingly on intermediate markers such as the insulin-like growth factors and potentially carcinogenic metabolites.

278 citations

Journal ArticleDOI
TL;DR: The associations between lignans and decreased risk of cardiovascular disease are promising, but they are yet not well established, perhaps due to low lignan intakes in habitual Western diets.
Abstract: The present review of the literature on lignan physiology and lignan intervention and epidemiological studies was conducted to determine if lignans decrease the risks of cardiovascular disease in Western populations. Five intervention studies using flaxseed lignan supplements indicated beneficial associations with C-reactive protein, and a meta-analysis that included these studies also suggested lignans have a lowering effect on plasma total and low-density lipoprotein cholesterol. Three intervention studies using sesamin supplements indicated possible lipid- and blood pressure-lowering associations. Eleven human observational epidemiological studies examined dietary intakes of lignans in relation to cardiovascular disease risk. Five showed decreased risk with either increasing dietary intakes of lignans or increased levels of serum enterolactone (an enterolignan used as a biomarker of lignan intake), five studies were of borderline significance, and one was null. The associations between lignans and decreased risk of cardiovascular disease are promising, but they are yet not well established, perhaps due to low lignan intakes in habitual Western diets. At the higher doses used in intervention studies, associations were more evident.

277 citations


Authors

Showing all 1345 results

NameH-indexPapersCitations
Walter C. Willett3342399413322
Meir J. Stampfer2771414283776
Frank B. Hu2501675253464
David J. Hunter2131836207050
Edward Giovannucci2061671179875
Irving L. Weissman2011141172504
Bernard Rosner1901162147661
Susan E. Hankinson15178988297
Paolo Boffetta148145593876
Jeffrey A. Bluestone14351577080
Richard D. Smith140118079758
Garth D. Illingworth13750561793
Brian E. Henderson13771269921
Ahmedin Jemal132500380474
Michael J. Thun12939279051
Network Information
Related Institutions (5)
University of Texas MD Anderson Cancer Center
92.5K papers, 4.7M citations

89% related

Memorial Sloan Kettering Cancer Center
65.3K papers, 4.4M citations

89% related

Fred Hutchinson Cancer Research Center
30.9K papers, 2.2M citations

88% related

Mayo Clinic
169.5K papers, 8.1M citations

86% related

University of California, San Francisco
186.2K papers, 12M citations

85% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
202312
20228
2021202
2020239
2019222
2018194